BONICK MARTIN (President and CEO) received a stock award from ARDENT HEALTH, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/2/2026ACC: 0001628280-26-023203
DirectorOfficer· President and CEO
Since Mar 2026
+115.64K
Net shares
Net buyer
$163.7K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
134.62K acquired · 18.98K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−8.03K
Price / share
$8.56
Trade value
$68.70K
% of position
0.6%
3/31/2026
1.32M→1.31M
Common Stock
Direct
Shares
−10.95K
Price / share
$8.67
Trade value
$94.95K
% of position
0.8%
4/1/2026
1.31M→1.30M
Common Stock
Direct
Shares
+134.62K
Price / share
—
Trade value
—
% of position
10.3%
4/1/2026
1.30M→1.44M
Total
Net shares
+115.64K
Net value
-$163.66K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/31/2026 | F · Tax Withholding | −8.03K | $8.56 | $68.70K | 0.6% | 1.32M | 1.31M |
| Common Stock Direct | 4/1/2026 | F · Tax Withholding | −10.95K | $8.67 | $94.95K | 0.8% | 1.31M | 1.30M |
| Common Stock Direct | 4/1/2026 | A · Award | +134.62K | — | — | 10.3% | 1.30M | 1.44M |
| Total | +115.64K | -$163.66K | ||||||
Derivative Transactions0
No derivative transactions reported